Results 121 to 130 of about 38,812 (326)

Acute liver disorders in the third trimester—AFLP, HELLP and infectious hepatitis—update on pathology, diagnosis and management

The Obstetrician &Gynaecologist, EarlyView.
Key content The epidemiology and pathophysiology of AFLP, HELLP syndrome and infectious viral hepatitis in late pregnancy. Clinical presentation, diagnosis and management of these conditions. Complications (maternal and fetal) and how these can be managed. The role of a multidisciplinary team in management.
Victor N. Chilaka, Mohammed Bashir, Theodore Ngatchu, Badreldeen Ahmed, Justin C. Konje   +4 more
wiley   +1 more source

Propofol Versus Methohexital in Electroconvulsive Therapy: Impact on Treatment Efficacy and Adverse Effects. A Systematic Literature Review and Meta‐Analysis

Acta Anaesthesiologica Scandinavica, Volume 69, Issue 7, August 2025.
ABSTRACT Background Electroconvulsive therapy (ECT) is a widely used treatment for depression, but the choice of the anesthetic that is used for induction may affect both clinical outcomes and the occurrence of adverse effects (AEs). Propofol and methohexital are frequently used in Finland, yet their relative impact on treatment efficacy and AEs ...
Saara H. Huoponen, Katrin Sisa, Tom Saari, Markku Taittonen, Ulla Ahlmén‐Laiho   +4 more
wiley   +1 more source

Evaluation of Antiemetic Consistency in Chemotherapy-Induced Nausea and Vomiting Among NHL Patients in Sana’a, Yemen

International Journal of General Medicine
Mohammed Mohammed Battah,1,2 Hadzliana Zainal,1 Doa’a Anwar Ibrahim,2 Nur Hafzan Binti Md Hanafiah,1 Syed Azhar Syed Sulaiman,1 Abdulsalam Halboup1,2 1Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang ...
Battah MM, Zainal H, Ibrahim DA, Hanafiah NHBM, Syed Sulaiman SA, Halboup A   +5 more
doaj  

Antiemetic Efficacy of Adding Olanzapine 5 mg to Aprepitant, Palonosetron and Dexamethasone-Sparing After Day Two for Cancer Patients Receiving Anthracycline and Cyclophosphamide

Cancer Management and Research, 2021
Marii Suehiro,1,* Yasuyuki Kojima,2,* Masaki Takahashi,3,* Yuka Ito,4 Takayuki Keira,1 Kiwako Ikegawa,1 Hiroko Minatogawa,1 Koichiro Tsugawa,2 Tsuneaki Tanaka1 1Department of Pharmacy, St.
Suehiro M, Kojima Y, Takahashi M, Ito Y, Keira T, Ikegawa K, Minatogawa H, Tsugawa K, Tanaka T   +8 more
doaj  

ANTIEMETICS [PDF]

, 1961

openalex   +1 more source

Use of Real‐World Claims Data to Assess the Prevalence of Concomitant Medications to Inform Drug–Drug Interaction Risk in Target Patient Populations

Clinical Pharmacology &Therapeutics, Volume 118, Issue 1, Page 146-155, July 2025.
A common issue in clinical drug development involves drug–drug interactions (DDI) that may lead to altered drug exposure and subsequent altered safety and efficacy of an investigational drug or concomitant medications (conmeds) in the target patient population.
Alice S. Tang, Logan Brooks, Denise M. Boudreau, Pascal Chanu, Amita Joshi, Bianca Vora, Rui Zhu   +6 more
wiley   +1 more source

A New Benzimidazole Antiemetic, Domperidone, for the Treatment of Postoperative Nausea and Vomiting [PDF]

, 1978
Robert J. Fragen, Nancy J. Caldwell
openalex   +1 more source

Mirtazapine Is Associated With Shorter Hospital Stay in Pediatric Avoidant Restrictive Food Intake Disorder—A Retrospective Chart Review

International Journal of Eating Disorders, Volume 58, Issue 7, Page 1345-1351, July 2025.
ABSTRACT Objective Avoidant restrictive food intake disorder (ARFID) is a relatively new diagnostic entity, and no medication has been approved. Recent data suggest that mirtazapine, a tetracyclic antidepressant, could improve outcomes in ARFID. We conducted a retrospective chart review to examine the effects of mirtazapine on ARFID treatment in youth.
Aman Chishti, Rachael E. Groh, Tamara R. Maginot, Lisa Adler, Megan E. Shott, Walter H. Kaye, Guido K. W. Frank   +6 more
wiley   +1 more source

Controlled Clinical Studies of Orally Administered Antiemetic Drugs

, 1969
Charles G. Moertel, Richard J. Reitemeier   +1 more
openalex   +2 more sources

Long-Term Use of Rimegepant 75 mg for the Acute Treatment of Migraine is Associated with a Reduction in the Utilization of Select Analgesics and Antiemetics

Journal of Pain Research
Terence Fullerton,1 Glenn Pixton2 1Internal Medicine and Infectious Disease, Pfizer Research and Development, Pfizer Inc., Groton, CT, USA; 2Statistics, Pfizer Inc., Groton, CT, USACorrespondence: Terence Fullerton, Internal Medicine and Infectious ...
Fullerton T, Pixton G
doaj